Back to Search
Start Over
Ketamine, but not guanosine, as a prophylactic agent against corticosterone-induced depressive-like behavior: Possible role of long-lasting pro-synaptogenic signaling pathway
- Source :
- Experimental Neurology
- Publication Year :
- 2020
- Publisher :
- Elsevier Inc., 2020.
-
Abstract
- Ketamine has been reported to exert a prophylactic effect against stress-induced depressive-like behavior by modulating the guanosine-based purinergic system. However, the molecular pathways underlying its prophylactic effect and whether guanosine also elicits a similar effect remain to be determined. Here, we investigated the prophylactic effect of ketamine and guanosine against corticosterone (CORT – 20 mg/kg, p.o.)-induced depressive-like behavior in mice. Furthermore, we characterized if the prophylactic response may be associated with mTORC1-driven signaling in the hippocampus and prefrontal cortex. A single administration of ketamine (5 mg/kg, i.p.), but not guanosine (1 or 5 mg/kg, p.o.), given 1 week before the pharmacological stress prevented CORT-induced depressive-like behavior in the tail suspension test (TST) and splash test (SPT). Fluoxetine treatment for 3 weeks did not prevent CORT-induced behavioral effects. A single administration of subthreshold doses of ketamine (1 mg/kg, i.p.) plus guanosine (5 mg/kg, p.o.) partially prevented the CORT-induced depressive-like behavior in the SPT. Additionally, CORT reduced Akt (Ser473) and GSK-3β (Ser9) phosphorylation and PSD-95, GluA1, and synapsin immunocontent in the hippocampus, but not in the prefrontal cortex. No alterations on mTORC1/p70S6K immunocontent were found in both regions in any experimental group. CORT-induced reductions on PSD-95, GluA1, and synapsin immunocontent were prevented only by ketamine treatment. Collectively, these findings suggest that ketamine, but not guanosine, exerts a prophylactic effect against depressive-like behavior, an effect associated with the stimulation of long-lasting pro-synaptogenic signaling in the hippocampus.<br />Highlights • CORT induces depressive-like behavior and hippocampal synaptogenic markers deficits. • Ketamine prevents CORT-induced behavioral and hippocampal synaptogenic alterations. • Guanosine or fluoxetine are unable to prevent the alterations induced by CORT. • Ketamine plus guanosine partially prevent CORT-induced reduced self-care behavior.
- Subjects :
- 0301 basic medicine
Male
mTORC1, Mechanistic target of rapamycin protein complex 1
Hippocampus
Stimulation
NMDA, N-Methyl-d-aspartate
Pharmacology
chemistry.chemical_compound
Mice
0302 clinical medicine
Akt, Protein kinase B
NSF, Novelty-suppressed feeding test
Prophylactic effect
MDD, Major depressive disorder
Corticosterone
i.p., Intraperitoneal
Prefrontal cortex
SPT, Splash test
Guanosine
Depression
Purinergic receptor
P70S6K, 70 kDa ribosomal protein S6 kinase
GSK, Glycogen synthase kinase-3β
CORT, Corticosterone
Antidepressive Agents
Neurology
Hindlimb Suspension
PSD-95, Postsynaptic density protein-95 kDa
Ketamine
ANOVA, Analysis of variance
medicine.drug
Research Paper
Signal Transduction
OFT, Open-field test
AMPA, Alpha-amino-3-hydroxy-methyl-5-4-isoxazole propionic acid
FST, Forced swimming test
p.o., Per oral
03 medical and health sciences
Developmental Neuroscience
medicine
Animals
TST, Tail suspension test
GluA1, AMPA receptor subunits 1
business.industry
FDA, Food and Drug Administration
Tail suspension test
030104 developmental biology
chemistry
Synapses
Pre-Exposure Prophylaxis
business
030217 neurology & neurosurgery
Subjects
Details
- Language :
- English
- ISSN :
- 10902430 and 00144886
- Volume :
- 334
- Database :
- OpenAIRE
- Journal :
- Experimental Neurology
- Accession number :
- edsair.doi.dedup.....88d54a0a0ce9de46337b6a4a20ac2dd2